Associated Partners

Associated Partners are regional and local authorities, businesses, and citizens who participate and contribute to both the Ulysseus long-term mission and to our regional development and to shape the future of the European Higher Education. They are involved in the co-creation and design thinking processes, in the plans and structures and in the programs of activities of Ulysseus.

Discover the full list of Ulysseus European University Associated Partners with more than 100 organisations.

Filter & Search





AGEL is the most successful private healthcare provider in Central Europe. It currently operates hospitals, polyclinics, a network of pharmacies, laboratories, distribution companies and other specialized medical facilities in the Czech Republic. It has been operating in Slovakia since 2006 through its subsidiary AGEL SK and operates twelve hospitals, a specialized hospital in Bratislava, an occupational health service and other companies related to the provision of health care. AGEL SK continues in Slovakia with its long-term goal of providing effective health care in economically stable medical facilities that it operates. The effort is to ensure their further development, which will be reflected in the growth of the quality of health services for the residents of the respective region. AGEL SK a.s. focuses on the development of hospitals not only as a whole, but also the expansion of care in individual fields of medicine. The company’s priority is quality, safe and high-quality healthcare. We place special emphasis on education in prevention. Continuity of treatment is an important element on the road to recovery for us. We support science, research, education, we cooperate intensively with schools and universities.

Pioneering trusted medical solutions to improve the lives we touch: Unomedical s.r.o. is a member of the global company Convatec. Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, and a promise to be forever caring, our products and services are available in over 100 countries. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. The company is a constituent of the FTSE 100 Index (LSE: CTEC) and in 2021 revenues were over $2 billion.